Access to medicine and healthcare services poses persistent challenges, especially in low-income regions with high out-of-pocket expenses. Pharmaceutical companies can play a key role in tackling this issue through innovative solutions, varying from short-term payment agreements to complex, long-term strategies like manufacturing partnerships and public/private collaborations.
Despite the prevalence of such solutions, their implementation remains intricate, impacting companies’ willingness to engage. CRA consultants have developed the PAVE framework—comprising planning, adoption, viability, and experience categories—to aid pharmaceutical firms in navigating solution planning and conception. This framework, adaptable to specific contexts, serves as a valuable starting point for internal alignment, viability assessment, and initial planning.
Read the article here.
